NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings

Not Applicable

Completed

Conditions: Addiction

Interventions: Other: Screening Only (SO) condition
Other: SUSIT Condition

First Posted Date: 2016-09-08

Last Posted Date: 2022-05-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 79

Registration Number: NCT02893514

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer

Not Applicable

Completed

Conditions: Quality of Life

Interventions: Other: Home Delivered, Medically Tailored Meals (HDTM)

First Posted Date: 2016-09-02

Last Posted Date: 2020-06-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 6

Registration Number: NCT02887235

Locations: 🇺🇸
NYU Perlmutter Cancer Center, New York, New York, United States

Imaging Biomarkers of Knee Osteoarthritis

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Device: PRISMA 3T MRI scanner (Siemens Medical Solutions)

First Posted Date: 2016-09-02

Last Posted Date: 2022-12-27

Lead Sponsor: NYU Langone Health

Target Recruit Count: 50

Registration Number: NCT02888119

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Safety Study of the Hypo-fractionated (Large Doses) Radiation Therapy in Post-menopausal Women With Breast Cancers

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Radiation: 6 Gy/ fraction

First Posted Date: 2016-08-30

Last Posted Date: 2018-12-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT02883985

Locations: 🇺🇸
NYU Perlmutter Cancer Center, New York, New York, United States

Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy

Not Applicable

Completed

Conditions: Atunomic Neuropathy

Interventions: Other: kinesiology tape around the hip, knee and ankle joints
Other: No kinesiology tape around the hip, knee and ankle joints

First Posted Date: 2016-08-24

Last Posted Date: 2020-09-22

Lead Sponsor: NYU Langone Health

Target Recruit Count: 16

Registration Number: NCT02876939

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Camp High 5: Evaluation of the Effect on Upper Limb Function

Not Applicable

Completed

Conditions: Hemiplegia
Neurological Injury

Interventions: Behavioral: Constraint induced movement therapy (CIMT)
Behavioral: Hand-arm bimanual intensive training (HABIT)

First Posted Date: 2016-08-23

Last Posted Date: 2017-04-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 10

Registration Number: NCT02875054

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma

Phase 1

Terminated

Conditions: Relapsed Hodgkin Lymphoma
Relapsed Non-Hodgkin Lymphoma

Interventions: Biological: Pembrolizumab
Drug: Lenalidomide

First Posted Date: 2016-08-23

Last Posted Date: 2020-08-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 6

Registration Number: NCT02875067

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
NYU Perlmutter Cancer Center, New York, New York, United States

Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease

Not Applicable

Withdrawn

Conditions: Parkinson's Disease

Interventions: Device: MAGSTIM Rapid2
Device: Transcranial Magnetic Stimulation (TMS)

First Posted Date: 2016-08-23

Last Posted Date: 2019-05-17

Lead Sponsor: NYU Langone Health

Registration Number: NCT02875041

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis

Phase 4

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: MTX therapy
Drug: Ticagrelor

First Posted Date: 2016-08-22

Last Posted Date: 2021-10-25

Lead Sponsor: NYU Langone Health

Target Recruit Count: 9

Registration Number: NCT02874092

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Vaccination Uptake (VAX) in PD

Not Applicable

Completed

Conditions: Parkinson's Disease

Interventions: Behavioral: Standard of Care
Behavioral: Home Visit Program (HVP)

First Posted Date: 2016-08-22

Last Posted Date: 2020-01-10

Lead Sponsor: NYU Langone Health

Target Recruit Count: 164

Registration Number: NCT02874274

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy